Breathing Tube Position and Patency Monitoring System

Information

  • Research Project
  • 6935725
  • ApplicationId
    6935725
  • Core Project Number
    R44HL080796
  • Full Project Number
    1R44HL080796-01
  • Serial Number
    80796
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/2005 - 18 years ago
  • Project End Date
    11/30/2005 - 18 years ago
  • Program Officer Name
    HARABIN, ANDREA L.
  • Budget Start Date
    6/1/2005 - 18 years ago
  • Budget End Date
    11/30/2005 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/18/2005 - 19 years ago
Organizations

Breathing Tube Position and Patency Monitoring System

[unreadable] DESCRIPTION (provided by applicant): [unreadable] The long-term objective of this project is to commercialize an endotracheal tube (ETT, breathing tube) incorporating a technology which can provide a multitude of clinically relevant information to aid in airway management. The system consists of a low-cost, disposable ETT containing several miniature sensors that are connected to an embedded microprocessor. The system can provide: instantaneous confirmation of proper tube placement during intubation (in breathing or non-breathing patients); quantification of ETT insertion depth past the vocal folds to within millimeters; location and degree of partial or full obstructions within the ETT lumen; appropriateness of ETT diameter fit to the trachea; and location of a suction catheter tip within the ETT lumen during suctioning. It is expected that this airway management tool will establish a new standard of care for the intubated patient by continuously monitoring the condition and position of ETTs thereby ensuring a clear and intact airway. Clinical use of these tubes can potentially reduce both the direct costs (e.g. chest x-rays to confirm tube placement, prophylactic suctioning procedures) and indirect costs (e.g. resulting from morbidity and mortality) associated with ETT use. A prototype of the system, which can be applied equally to adult and infant sized ETTs, has been evaluated in preliminary animal and human infant studies with excellent results. However, the prototype is not robust or miniature enough for clinical use and thus requires additional research before moving forward. The key phase I aim is to conduct in vitro studies to design and develop an optimal miniature system while ensuring that the design can be mass produced at a low cost. Successful completion of this aim will significantly reduce the technology risk associated with the phase II development of a reliable and low-cost commercial system. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    838
  • Ed Inst. Type
  • Funding ICs
    NHLBI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SONARMED, INC.
  • Organization Department
  • Organization DUNS
    198245628
  • Organization City
    Indianapolis
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    462684184
  • Organization District
    UNITED STATES